971.1500 7.55 (0.78%)
NSE Apr 02, 2026 15:31 PM
Volume: 212.2K
 

971.15
0.78%
Geojit BNP Paribas
Management remains optimistic about performance in other regulated markets, anticipating stronger revenue growth in FY26 as European partners prepare for product launches. The company also expects these markets to eventually generate...
Geojit BNP Paribas upgraded Strides Pharma Science Ltd. to Buy with a price target of 1119.0 on 27 Mar, 2026.
More from Strides Pharma Science Ltd.
Recommended